Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Hepregen Launches First Human HepatoPac™ Assay Kit
Wednesday, March 26, 2014
Application-directed kit provides information useful in predicting potential drug-induced liver injury.

Optibrium and Integrated Chemistry Design Collaborate
Tuesday, March 25, 2014
Asteris for iPad enables drug discovery scientists to quickly explore high quality compound ideas.

Cellular Dynamics Announces Presentations at the SOT Annual Meeting
Saturday, March 22, 2014
Highlighting use of iPSC-derived human cells for environmental toxicology and drug toxicity testing.

Sensitive and Simple Determination of Monochloroacetic Acid in Carbocisteine
Friday, March 14, 2014
New approach is sensitive and easier to use than other methods.

Malvern Instruments at Analytica 2014
Wednesday, March 12, 2014
Malvern Instruments shows how complementary technologies solve analytical challenges from biopharm to bulk materials.

Bio-Rad Announces New Technology for the Identification of Unknown Compounds with Infrared and Raman Spectroscopy
Tuesday, March 11, 2014
New technologies combine Bio-Rad's years of accumulated knowledge in the field of spectroscopy with advanced computational power

Phenomenex Announces New Kinetex Core-Shell Biphenyl Columns
Tuesday, March 04, 2014
Expands selectivity of Kinetex® core-shell line.

Promega Introduces GloMax Discover Multimode Detection System
Friday, January 31, 2014
New plate reader system provides superior sensitivity, performance, and flexibility with minimal user intervention.

Waters Introduces UPLC System for nano- to Microscale Separations
Wednesday, January 29, 2014
New UPLC system and columns drive separations efficiency and the sensitivity of LC-MS analyses to new levels.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 649
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv